Santhera Pharmaceuticals Holding AG (SPHDF)
USD 17.01
(5.0%)
USD 17.01
(5.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 81.85 Million USD | 220.93% |
| 2022 | -49.6 Million USD | 20.8% |
| 2021 | -62.62 Million USD | -3.35% |
| 2020 | -60.59 Million USD | -789.35% |
| 2019 | -6.81 Million USD | 86.97% |
| 2018 | -52.27 Million USD | -0.56% |
| 2017 | -51.98 Million USD | -58.28% |
| 2016 | -32.84 Million USD | -41.98% |
| 2015 | -23.13 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -9.87 Million USD | -0.4% |
| 2024 Q1 | -9.83 Million USD | -111.69% |
| 2023 Q2 | -22.71 Million USD | -104.71% |
| 2023 FY | 59.98 Million USD | 220.93% |
| 2023 Q1 | -11.09 Million USD | 49.5% |
| 2023 Q3 | 39.03 Million USD | 271.82% |
| 2023 Q4 | 84.14 Million USD | 115.56% |
| 2022 Q2 | -26.71 Million USD | 0.0% |
| 2022 Q4 | -21.97 Million USD | -94.21% |
| 2022 FY | -49.6 Million USD | 20.8% |
| 2022 Q3 | -11.31 Million USD | 57.64% |
| 2021 Q2 | -21.03 Million USD | 0.0% |
| 2021 FY | -62.62 Million USD | -3.35% |
| 2021 Q4 | -41.3 Million USD | 0.0% |
| 2020 Q2 | -27.44 Million USD | 0.0% |
| 2020 FY | -60.59 Million USD | -789.35% |
| 2020 Q4 | -31.18 Million USD | 0.0% |
| 2019 FY | -6.81 Million USD | 86.97% |
| 2019 Q4 | 12.17 Million USD | 0.0% |
| 2019 Q2 | -22.95 Million USD | 0.0% |
| 2018 FY | -52.27 Million USD | -0.56% |
| 2017 FY | -51.98 Million USD | -58.28% |
| 2016 FY | -32.84 Million USD | -41.98% |
| 2015 FY | -23.13 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 6229.25% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 1722.602% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 558.631% |
| Nascent Biotech, Inc. | -2.22 Million USD | 3770.688% |
| Rebus Holdings, Inc. | -664 Thousand USD | 12427.094% |
| Qrons Inc. | -643.67 Thousand USD | 12816.301% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | 21110.833% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 247.46% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 19800.612% |
| Skye Bioscience, Inc. | -13.67 Million USD | 698.691% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 214.022% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -1565.413% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | 31373.891% |
| SQZ Biotechnologies Company | -75.82 Million USD | 207.948% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 2971.486% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 5428.73% |
| Mesoblast Limited | -84.14 Million USD | 197.273% |
| Marizyme, Inc. | -34.08 Million USD | 340.13% |
| Genus plc | 6.4 Million USD | -1178.936% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | -740.157% |
| Pharming Group N.V. | -4.87 Million USD | 1777.45% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 4220.452% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 8888.239% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 1080.262% |
| ContraFect Corporation | -56.88 Million USD | 243.88% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 1897.076% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 5938.262% |
| IMV Inc. | -38.67 Million USD | 311.659% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 3075.525% |
| MultiCell Technologies, Inc. | -722.81 USD | 11324224.459% |
| ONE Bio Corp. | 13.68 Million USD | -498.265% |
| Accustem Sciences Inc. | -3.74 Million USD | 2284.804% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 238.756% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | 17044.389% |
| Q BioMed Inc. | -3.44 Million USD | 2475.538% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | -2212.201% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 3215.175% |
| Biomind Labs Inc. | -1 Million USD | 8207.336% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 248.896% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 2921.263% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 1331.223% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 4490.325% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | 273376.923% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 615.774% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 4335.304% |
| GB Sciences, Inc. | -1.42 Million USD | 5862.153% |
| Alpha Cognition Inc. | -9.7 Million USD | 943.347% |
| HST Global, Inc. | -140.9 Thousand USD | 58189.31% |
| CSL Limited | 3.7 Billion USD | 97.789% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 7376.333% |
| Halberd Corporation | -75.05 Thousand USD | 109163.163% |
| Enzolytics Inc. | -2.14 Million USD | 3909.191% |
| Agentix Corp. | -1.37 Million USD | 6066.943% |
| Resverlogix Corp. | -12.74 Million USD | 742.026% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 2683.486% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -425.04 Million USD | 119.257% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 7940.221% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 2903.681% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 5282.616% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 2503.889% |
| AVAX Technologies, Inc. | 6.69 Million USD | -1122.97% |
| Zenith Capital Corp. | -8.94 Million USD | 1015.262% |
| Genscript Biotech Corporation | -415.79 Million USD | 119.686% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 469946.186% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 3433.659% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | 47824.403% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 4182.884% |
| Kadimastem Ltd | -3.04 Million USD | 2792.275% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 8417.835% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 6616.871% |
| BioStem Technologies, Inc. | -7.77 Million USD | 1152.22% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | 45201.195% |
| LadRx Corporation | -3.82 Million USD | 2240.688% |
| Cell Source, Inc. | -4.32 Million USD | 1992.378% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 12015.264% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 12015.264% |
| NovAccess Global Inc. | -2.46 Million USD | 3418.195% |
| Affymax, Inc. | -15.04 Million USD | 644.011% |
| Itoco Inc. | -919.14 Thousand USD | 9005.271% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 2031.192% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 7414.737% |
| Mobile Lads Corp. | -554.55 Thousand USD | 14860.058% |
| CytoDyn Inc. | -18.05 Million USD | 553.272% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | 325296.281% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | 37292.225% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 14594.169% |
| SYBLEU INC | -149.18 Thousand USD | 54967.88% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 4606.469% |
| International Stem Cell Corporation | -663 Thousand USD | 12445.687% |
| Bioxytran, Inc. | -3.82 Million USD | 2242.638% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 155593.739% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | 402518.407% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 325.699% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 5158.832% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 11223.676% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 2731.048% |
| Neutra Corp. | -229.48 Thousand USD | 35767.493% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 566.685% |
| PureTech Health plc | -146.19 Million USD | 155.987% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 480.864% |
| IXICO plc | -1.43 Million USD | 5796.027% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 962.416% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 167.199% |
| CSL Limited | 3.81 Billion USD | 97.853% |
| Cellectis S.A. | -108.85 Million USD | 175.192% |